#LCSM Chat Topic 03-Jun-2021: Making the Most of #ASCO21

Oncology conferences such as those offered by ASCO (American Society for Clinical Oncology), ESMO (European Society for Medical Oncology), and IASLC (International Association for the Study of Lung Cancer) are premier sources for connecting with others in the  lung cancer community, learning about different aspects of lung cancer research and policy, and highlighting key research results.  The entire lung cancer community can help in disseminating results of research that impacts us.   On Thursday, June 3, at 8 pm Eastern Time (5 pm Pacific), #LCSM Chat will discuss ways the community make… Read More

#LCSM Chat Topic 6-May-2021: The Hows and Whys of Cancer Research Advocacy

Cancer patient advocates first appeared decades ago, in the breast cancer community.  Patient advocates are dedicated to supporting patients and their loved ones, improving lung cancer education and awareness, and generating funds for advocacy and research.  With the advent of targeted therapies and immunotherapies for many types of cancer, the past ten years have seen a growing group of patients, survivors, and caregivers who have lived with cancer long enough to become active, knowledgeable advocates for their cancer community. There is another type of cancer patient advocate called a “research advocate.” Research… Read More

#LCSM Chat Topic 1-Apr-2021: Tell Us What You Want — We’re Listening

#LCSM Chat began almost eight years ago.  Since then, lung cancer screening, diagnosis, care, and treatment options — as well as social media platforms — have changed dramatically.  The #LCSM Chat team decided it was time to make some changes of our own.   Our first change is a happy announcement:  please join us in welcoming medical oncologist Charu Aggarwal, MD, MPH (@CharuAggarwalMD) to the #LCSM Chat Moderator Team! Charu is the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at Penn Medicine.  Our second change is a survey of #LCSM Chat… Read More